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ABSTRACT Pediatric cataract is a leading cause of childhood blindness. This study aimed to determine the
genetic cause of pediatric cataract in Australian families by screening known disease-associated genes using
massively parallel sequencing technology. We sequenced 51 previously reported pediatric cataract genes in
33 affected individuals with a family history (cases with previously known or published mutations were excluded)
using the Ion Torrent Personal GenomeMachine. Variants were prioritized for validation if they were predicted to
alter the protein sequence and were absent or rare with minor allele frequency ,1% in public databases.
Confirmed mutations were assessed for segregation with the phenotype in all available family members. All
identified novel or previously reported cataract-causing mutations were screened in 326 unrelated Australian
controls. We detected 11 novel mutations in GJA3, GJA8, CRYAA, CRYBB2, CRYGS, CRYGA, GCNT2, CRYGA,
and MIP; and three previously reported cataract-causing mutations in GJA8, CRYAA, and CRYBB2. The most
commonly mutated genes were those coding for gap junctions and crystallin proteins. Including previous reports
of pediatric cataract-associated mutations in our Australian cohort, known genes account for .60% of familial











Pediatric cataract is one of the leading causes of blindness in children.
Approximately 200,000 children worldwide are blind from this
condition (Chan et al. 2012). In industrialized countries, the inci-
dence is 1–6 per 10,000 live births (Santana and Waiswo 2011). In
Australia, the incidence is 2.2 per 10,000 live births, making the
condition one of the most common causes of visual impairment in
children (Wirth et al. 2002). Intrauterine infection, drug exposure,
metabolic disorders, malnutrition, and heredity are known risk fac-
tors for pediatric cataract (Churchill and Graw 2011). Pediatric cat-
aract is often referred to as congenital or infantile cataract when it
presents at birth or in the first year of life, and juvenile cataract when
it presents later during childhood (Yi et al. 2011).
Around 25–33% of pediatric cataracts are inherited (Santana et al.
2009). It is thought that 28% of bilateral pediatric cataract cases have
a genetic basis while only 2% of unilateral cases are genetic (Rahi
and Dezateux 2001; Santana and Waiswo 2011). Genetic and clinical
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heterogeneity have been reported in inherited pediatric cataracts
(Lorenz 2007). Inherited cataracts can be transmitted as autosomal
recessive, autosomal dominant, or X-linked traits, with autosomal
dominant being the most common mode of inheritance. They can
be isolated (nonsyndromic) or combined with other phenotypic fea-
tures (syndromic) (Hejtmancik 2008).
Changes in lens development including lens fiber cell differen-
tiation, protein solubility and stability, and defects in lens structure
can lead to the development of cataract (Huang and He 2010).
Mutations in genes involved in these functions have been reported
to cause pediatric cataract. The known genes include at least 10 crys-
tallin genes (Churchill and Graw 2011; Berry et al. 2001; Kannabiran
et al. 1998; Riazuddin et al. 2005; Willoughby et al. 2005; Litt et al.
1997, 1998; AlFadhli et al. 2012; Heon et al. 1999), as well as mem-
brane proteins [MIP, LIM2 (Pras et al. 2002; Berry et al. 2000)]; gap
junction proteins [GJA8, GJA3 (Beyer and Berthoud 2014)], cyto-
skeletal proteins [BFSP1, BFSP2 (Ramachandran et al. 2007; Jakobs
et al. 2000)]; stress response genes [HSF4 (Bu et al. 2002)], cell
signaling proteins [EPHA2 (Shiels et al. 2008)], and transcription
factors [PITX3, PAX6, EYA1, FOXE3, VSX2, FTL and MAF
(Churchill and Graw 2011; Burdon et al. 2007; Shiels et al. 2007;
Santana and Waiswo 2011)]. Crystallin and gap junction protein-
encoding genes are the most commonly reported classes of genes for
nonsyndromic pediatric cataracts, accounting for 50 and 25% of
reported mutations, respectively (Hejtmancik 2008).
The large number of genes known to cause pediatric cataract and
the limited genotype-phenotype correlations make clinical testing
using traditional sequencing technologies challenging and expensive.
Massively parallel (next-generation) sequencing (MPS) technolo-
gies are now accessible and are cost-effective tools to screen many
candidate genes in parallel. In this study, we screened our repository
of South Eastern Australian individuals with familial pediatric
cataract for mutations in known causative genes using the Ion
Torrent Personal Genome Machine (PGM). We hypothesized that
a significant proportion of familial pediatric cataract cases would be
accounted for bymutations in known genes, and that screening genes
in parallel would be an effective method for genetic testing in this
heterogeneous disease.
MATERIALS AND METHODS
Participants’ recruitment and DNA extraction
The study adhered to the tenets of the Declaration of Helsinki and
was approved by the Southern Adelaide Clinical Human Research
Ethics Committee, Adelaide, Australia, and the Royal Victorian
Eye and Ear Hospital (RVEEH) Human Research and Ethics
Committee, Melbourne, Australia. The probands in each family
were recruited from the eye clinic at Flinders Medical Centre
(Adelaide), the Women’s and Children’s Hospital (Adelaide),
the Royal Children’s Hospital (Melbourne), or the Royal Victo-
rian Eye and Ear Hospital (Melbourne). Written informed con-
sent was obtained from all participants or their guardians if they
were under 18 years old. A detailed family history was obtained
and additional affected and unaffected family members were in-
vited to participate in the study. An ophthalmologist examined all
available family members.
Genomic DNA was extracted from either peripheral whole blood
using a QiaAmp DNA Blood Maxi Kit (Qiagen, Hilden, Germany) or
from saliva using anOragene DNA saliva collection kit (DNAGenotek,
Ontario, Canada) according to the manufacturers’ protocols. Partici-
pants were included in this study if they reported a family history of
pediatric cataract and if a causative mutation had not previously been
detected in the family by other means.
Gene selection, primer design, library preparation,
and sequencing
Fifty-one genes known to cause pediatric cataract in human or mouse
were selected through review of the literature (Supplemental Material,
Table S1 in File S1 (Chen et al. 2011; Churchill and Graw 2011; Hughes
et al. 2011; Lachke et al. 2011; Aldahmesh et al. 2012; Pras et al. 2004;
Azuma et al. 2000; Nonnenmacher et al. 2011; Jamieson et al. 2007;
Shiels et al. 2007; Zhou et al. 2010; Ferda Percin et al. 2000; Reis et al.
2012). The strategy for generating the list included all genes covered in a
review of pediatric cataract genes (Churchill andGraw 2011) except the
mouse gene gjf1, which does not have a human homolog (n = 39). A
search in PubMed using the terms “paediatric cataract” or “congenital
cataracts” in combination with “genetic” or “gene” was used to include
additional genes from more recent publications and those genes not
covered by the review (n = 12).We focused on those genes known to be
associated with nonsyndromic pediatric cataract, as this was the pre-
dominant phenotype in our cohort. In addition, we included some
syndromic pediatric cataract genes known to cause a predominantly
ocular syndrome (e.g., PAX6 and PITX3) orwhere pediatric cataract is a
major diagnostic feature of the syndrome (NHS) as such genesmay also
contribute to nonsyndromic cataract (Gillespie et al. 2014).
PCR primers to amplify coding, 39-, and 59-untranslated regions
of the 51 genes were designed with the Ion AmpliSeq Designer
tool v1.22 (Life Technologies, www.ampliseq.com). The final de-
sign consisted of a total of 1216 amplicons ranging from 125 to
225 bp, covering 94.26% of the target sequence. Primers were sup-
plied in two 100 nM pools (Life Technologies, Carlsbad, CA).
Briefly, the concentration of genomic DNA was determined using
the dsDNA HS Assay Kit on a Qubit fluorometer (Life Technolo-
gies), and libraries were prepared with the Ion AmpliSeq library kit
version 2.0 according to manufacturer’s protocols. Libraries were
prepared in two pools per individual, and the amplified pools were
combined before partially digesting the primers and barcode adap-
tor ligation. The amplified library was diluted to 10 pM, and 25 ml of
the diluted library was used for template preparation using Ion
PGM Template OT2 200 Kit (Life Technologies) and the manufac-
turer’s protocol. The clonally amplified library was then enriched on
an Ion OneTouch enrichment system. Samples were barcoded dur-
ing library preparation using Ion Xpress Barcode Adapters 1–16 kit
(Life Technologies) and pooled in groups of 3–5 during template
preparation on the Ion OneTouch.
Libraries were quantified either with a Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA) using the High Sensitivity DNA Kit
(Agilent Technologies), or by qPCR using the Ion library TaqMan
quantification kit (Life Technologies). Sequencingwas performed on an
IonTorrentPGMusingThe IonPGMSequencing200Kit v2and an Ion
318 chip (Life Technologies).
Torrent Suite (version 3.6)was used to align reads tohuman genome
reference sequence 19 (hg19). The Coverage Analysis plugin (v4.0-
r77897) was used to calculate the number of mapped reads, the
percentage of on-target reads, and the mean depth of reads. Variants
were called using the Variant caller plugin (V4.0-r76860) with the
germline algorithm [allele frequency of 0.15, minimum read quality
of 10, and minimum coverage of 20 were set as cut-offs for both indels
and single nucleotide polymorphisms (SNPs)]. For annotation, variant
call format (VCF) files were uploaded to Ion Reporter V4.0 (https://
ionreporter.lifetechnologies.com/ir/) using the Ion Reporter Uploader
plugin for Torrent Suite (v4.1-r79929). Variants were prioritized for
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further analysis if they were predicted to be protein-changing, and were
absent or rare with minor allele frequency (MAF) ,1% in dbSNP137
(http://www.ncbi.nlm.nih.gov/projects/SNP/), the Exome Aggregation
Consortium (ExAC) (http://exac.broadinstitute.org/), and gnomAD
(http://gnomad.broadinstitute.org/). In addition, identified variants
were compared with an in-house list of common sequencing errors
previously detected with this gene panel.
Validation, segregation analysis, and evaluating
potential functional effects of mutations
Direct Sanger sequencing was used to confirm the detected protein-
changing mutations in probands and to evaluate the segregation of the
mutation in families. Forward and reverse primer sequences were
designed using Primer3 (Untergasser et al. 2012; Koressaar and Remm
2007) and are listed in Table S2 in File S1.
PCR reactions of 20 ml final volume consisted of 1· Coraload PCR
buffer (Qiagen), which gave a final concentration of 1.5 mM Mg2+,
0.1 mM dNTPs (Roche Diagnostics, Risch-Rotkreuz, Switzerland),
0.5 mM of each primer, 0.5 U Hot Star Plus Taq Polymerase (Qiagen),
and 40 ng of gDNA. Five times Q Solution (Qiagen) was included at a
final concentration of 1· as required, and water volume was adjusted
accordingly. PCR was performed on a Palm Cycler (Corbett Life sci-
ence,Qiagen)with one cycle at 95 for 5min, followed by 30 or 35 cycles
(Table S2 in File S1) at 95 for 30 sec, 57265 (annealing temperature,
Table S2 in File S1) for 30 sec, and 72 for 30 sec, and a final extension
step at 72 for 5 min. To clean the PCR products for sequencing, 5ml of
PCR product, 2 ml shrimp alkaline phosphatase (SAP; 1 unit/ml) and
0.5 ml (20 units/ml) of exonuclease 1 (Exo1) (New England Biolabs,
Massachusetts) were mixed. Reactions were incubated at 37 for 1 hr,
followed by incubation at 80 for 20 min to inactivate the enzymes.
Sequencing reactions were prepared with the respective forward
primer at 5 mM and purified PCR product at 10 ng/100 bp (i.e., 30 ng
for 300 bp product) combined with BigDye Terminator v3.1 (Life
Technologies) and 5· Sequencing Buffer (Life Technologies), andmade
up to 20ml withwater. Reactionswere taken through a cycle sequencing
PCR protocol on a MasterCycler thermal cycler (Eppendorf, Hamburg,
Germany). PCR extension products were purified using Agencourt
CleanSeq Magnetic Beads and a SPRI plate, according to the manu-
facturer’s protocol (Beckman Coulter, California). Purified extension
products were then resolved using POP-7 polymer on the 3130xl Genetic
Analyzer (Life Technologies) in the Flinders Sequencing Facility (Flinders
Medical Centre, Adelaide, Australia).
Sequence chromatograms of affected and unaffected individuals
were compared to each other and the reference sequence using
Sequencher v.5 (GeneCodes Corporation, Ann Arbor, MI).
Each confirmed segregating novel mutation was assessed for a
potential functional effect on the predicted protein sequence using SIFT
(Sorting Intolerant from Tolerant, http://sift.jcvi.org/) (Kumar et al.
2009) and Polyphen-2 (version 2.2.2; the default HumDiv model was
used) (Adzhubei et al. 2010) (http://genetics.bwh.harvard.edu/pph2/).
The conservation of each altered amino acid was calculated using PhyloP
as implemented in Mutation Taster (http://www.mutationtaster.org/)
and available through the University of California Santa Cruz (UCSC)
genome browser. PhyloP values between214 and +6 indicate conser-
vation at individual nucleotides, ignoring the effects of their neighbors.
Amino acid conservation across species was visualized using the Mu-
tation Taster website. Clinical interpretation of genetic variants by the
2015 ACMG/AMP guideline was determined using InterVar (http://
wintervar.wglab.org) (Li and Wang 2017; Richards et al. 2015).
Screening novel or previously reported variants in
control population
Novel variants were screened in 326 unrelated normal Australian
controls recruited from Flinders Medical Centre, Adelaide, using the
MassArray platform and iPlEX chemistry (Sequenom) at theAustralian
Genome Research Facility (Brisbane, Australia). Variants identified in
familiesCRCH139,CSA133, andCSA95werescreened incontrols using
customTaqManSNPgenotypingassays(LifeTechnologies)onaStepOne
Plus real-time PCR instrument (Life Technologies) using standard
manufacturer’s protocols. All variants reported in this study have
been submitted to the ClinVar database (http://www.ncbi.nlm.nih.
gov/clinvar/; ClinVar accessions SCV000297746–SCV000297762).
Data availability
Table S1 in File S1 contains a list of reported pediatric cataract genes
selected for sequencing. PCR primers used to validate novel or rare
coding mutations detected by next-generation sequencing are listed
in Table S2 in File S1. Table S3 in File S1 contains systemic features
of the five participants with syndromic pediatric cataract included in
the study. Figure S1 in File S1 shows amplicons with,20 fold coverage.
Figure 1 Average fold coverage of target genes sequenced from AmpliSeq libraries in 33 probands with pediatric cataract.
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Figure S2, A–C in File S1) shows protein sequence alignments demon-
strating the conservation of the altered amino acid in families with
causative mutations.
RESULTS AND DISCUSSION
We sequenced 51 known pediatric cataract genes in 33 unrelated
probands using Ion Torrent MPS technology. Syndromic cataract
was present in 5/33 (15%) probands (syndromic features described in
Table S3 in File S1) while 28/33 (85%) probands had isolated pediatric
cataract. Primers were designed for 1216 amplicons in the size range of
125–225 bp to cover the 51 known causative genes. In total, 154.1 kb of
target sequence was included in the design process with amplicons
designed for 94.3% of the target sequence (8.8 kb not covered). The
presence of repetitive sequence, unacceptable GC content, and melting
temperatures of the primers outside the optimal range were the main
factors limiting primer design for target regions not covered.
The mean number of mapped reads per sample was 1,536,538, with
91%of readson target.Ameanof1155 readswasachievedper amplicon,
withacoverageuniformityof89%.Ofall theamplicons,96and91%were
covered at least 20 and 100 fold, respectively. The average coverage per
gene is shown in Figure 1. Of the 1216 amplicons, 30 amplicons (2%)
across 17 genes were covered ,20 fold (Figure S1 in File S1).
A total of 4726 variants were annotated (an average of 139 variants
per individual). In total, 178 variants were absent/rare (MAF,1%) in
publically referenced databases, of which 56 were nonsynonymous
exonic variants. Twenty-three variants were selected for validation
n Table 2 Observed phenotypes in families with causative mutations identified in pediatric cataract associated genes
Family Gene Affected Members Phenotype Age at Diagnosis Age at Surgery Age at SurgeryRight Eye Left Eye
CSA95 GJA3 CSA95.01 — 0 yr 0 yr 0 yr
CSA95.02 — 20 yr — —
CSA109 GJA3 CSA109.01 Fetal nuclear cataract 3 yr — —
CSA109.02 Fetal nuclear/lamellar
cataract
5 yr 16 yr 17 yr
CRCH20 GJA8 CRCH20.02 Bilateral congenital nuclear — 35 yr —
CRCH20.07 Bilateral minor lens
opacities
— — —
CSA125 GJA8 CSA125.01 Nuclear 10 yr — —
CSA125.02 Posterior polar — 6 yr —
CSA162 GJA8 CSA162.01 — — — —
CSA162.02 — — — —
CSA159 CRYAA CSA159.01 Severe congenital 0 yr 1 mo 2 mo
CSA159.02 Nuclear and cortical,
blue-dot component: mild
19 yr 25 yr 25 yr
CSA159.04 Lamellar: mild 4 yr NA NA
CRVEEH111 CRYAA CRVEEH111.01 Bilateral — — —
CRVEEH111.04 Bilateral — 17 mo 17 mo
CRVEEH111.05 Central, anterior polar rider,
faint nuclear opacity only
— — —
CRVEEH111.06 Central nuclear opacity — — —
CSA94 CRYGS CSA94.01 Lamellar cortical-nuclear
clear
6 yr 6 yr 5 yr
CSA94.02 Cortical 4 yr 6 yr 5 yr
CSA94.03 Lamellar 2 yr 3 yr 4 yr
CSA94.04 Lamellar 2 yr 5 yr 5 yr
CRCH139 CRYGA CRCH139.02 Congenital — — —
CSA133 CRYBB2 CSA133.01 — — — —
CSA133.03 — — — —
CRVEEH85 CRYBB2 CRVEEH85.01 Congenital — — —
CRVEEH85.02 Congenital 2–3 yr 3 yr 3 yr
CRVEEH85.03 Congenital — — —
CRCH89 GCNT2 CRCH89.01 Bilateral congenital — 3 wk 3 wk
CRCH89.02 Bilateral congenital — 1 yr 1 yr
CRCH89.05 Bilateral congenital — — —
CRCH89.07 Bilateral congenital — — —
CRCH136a GCNT2 CRCH136.01 Bilateral dense central
opacity
— — —
CRCH136.02 Bilateral dense central
opacity
— — —
CSA131 MIP CSA131.01 White dots 20 yr NA NA
CSA131.02 White dots 22 yr NA NA
CSA131.04 Cortical and nuclear sclerotic,
multiple cortical dots as well
as anterior cortical spokes
45 yr 46 yr 46 yr
Missing data are indicated by “—”. NA indicates the individual has not had surgery to date.
a
One heterozygous deletion detected in affected members of this family with autosomal recessive inheritance pattern.
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using Sanger sequencing after filtering out the variants in an in-house
list of sequencing artifacts (33 variants). Seventeen variants were vali-
dated and six were false positives.
Of the 17 validated variants (Table 1), 14 appeared to be the likely
cause of cataract in the respective families, accounting for 42% of the
33 screened probands. The validated mutations were considered to be
pathogenic if the protein change was predicted to be pathogenic by
SIFT (Kumar et al. 2009) and/or Polyphen-2 (Adzhubei et al. 2010), the
variant segregated with the phenotype in the family, and was absent
from all screened local controls. Two of the 17 validated variants did
not segregate, and one was considered benign by both SIFT and Poly-
phen-2. All segregating mutations were highly conserved across species
(Figure S2, A–C in File S1 and Table 1). We have used Polyphen-2 and
SIFT predictions as a pathogenicity indicator guide; however, the pre-
dictions based on ACMG (Richards et al. 2015; Li and Wang 2017)
guideline were also included for clinical purposes. The variants pre-
dicted to have uncertain significance under ACMG guideline look
promising based on the evidence generated in this study; however,
additional studies will be needed to confirm their pathogenicity.
In total, as shown inTable 1,we detected 11novelmutations in eight
different genes (GJA3, GJA8, CRYAA, CRYBB2, CRYGS, CRYGA,
GCNT2, CRYGA, andMIP), three previously reported cataract-causing
mutations in three different genes (GJA8, CRYAA, and CRYBB2). The
phenotype in each of the 14 families is given in Table 2, and represen-
tative clinical photos where available are shown in Figure 2.
We identified novel mutations in two gap junction genes (GJA3 and
GJA8) in five families. Of the two families (CSA95 and CSA109) with
mutations in GJA3, phenotypic information was not available for family
CSA95, but variant p.Thr19Met was predicted to be pathogenic and
segregated in the two affected individuals (Figure 3). Both tested individ-
uals in family CSA109 had fetal nuclear lamellar cataracts (Figure 2) and
the variant p.(Lys156Gln) was predicted to be damaging and segregated
in two affected siblings. The affected father was not available for testing.
Two of the three families with GJA8 mutations (CSA125 and
CRCH20) had cataracts described as nuclear, with no phenotype
information available for family CRCH162 (Table 2). In family CRCH20
the damaging mutation [p.(Trp25Arg)] segregated in two generations
and appeared to have incomplete penetrance, as individual CRCH20.04
carries the mutation but as yet does not have cataract. Mutations in
families CSA162 [p.(Trp45Ser)] and CSA125 [p.(Glu162Lys)] were
inherited from the affected mother and the affected father, respectively
(Figure 3), and segregated with the disease.
Six mutations were identified in crystallin genes. A previously
reported mutation (Khan et al. 2007; Devi et al. 2008) in CRYAA
[p.(Arg54Cys)] was detected in family CRVEEH111 that segregated
with the disease (Figure 4A). SIFT predicted this variant to be toler-
ated, but Polyphen-2 predicted it to be pathogenic (Table 1). Family
CRVEEH111 had central nuclear cataract with varying severity in
affected family members. The second mutation detected in CRYAA
is a novel frameshift deletion [p.(Gln147Argfs48)] in a consanguineous
family (CSA159) displaying autosomal dominant inheritance (Figure
4A). The father and both children carried the mutation; however, the
severity of the phenotype varied between affected members. The pro-
band (CSA159.01) was diagnosed at birth and underwent cataract
surgery at 1 month of age. His sister (CSA159.04) was diagnosed with
amilder lamellar cataract with a similar appearance to that in the father.
One novel and one previously reported mutation were detected in
CRYBB2. Three affected individuals from family CRVEEH85 carried a
novel mutation [p.(Arg188Leu)]. These individuals also carried a var-
iant in BFSP2 [p.(Ala379Glu)]. However, this variant was reported to
be benign by both SIFT and Polyphen-2 and was less conserved. It was
therefore considered not pathogenic. A previously reported truncating
mutation, p.(Gln155) (rs74315489), in the CRYBB2 gene was identi-
fied in two affected individuals in family CSA133. No information was
available regarding the phenotype in this family. This variant has not
been reported in normal populations and was not detected in our local
controls, thus is likely pathogenic.
Three mutations were detected in two different g-crystallin genes.
Family CSA94 (Figure 4B) had a novel dinucleotide substitution
(c.30_31delCTinsAA) resulting in the substitution of two amino
Figure 2 Phenotype of pediatric cataract in family CSA109 carrying causative mutations in GJA3. Photographs of individual CSA109.01 A–C show
fetal nuclear cataract. D–F show fetal nuclear/lamellar cataract in individual CSA109.02.
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acids [p.(Phe10_Tyr11delinsLeuAsn]) in CRYGS which was pre-
dicted to be damaging (Table 1). Affected members of this family
had a juvenile onset cortical lamellar cataract and all the members had
surgery by 6 yr of age (Table 2). Family CRCH139 had a missense
variant [p.(Arg80His), rs139353014] in CRYGA segregating with the
phenotype in three individuals. This variant was predicted to be dam-
aging by Polyphen-2 and the residue was conserved across species.
However, it had aMAF of 0.2% in dbSNP, 0.4% in the ExAC database,
and 0.1% in our Australian controls. The variant was also present in
an unaffected individual CRCH139.03 in this family (Figure 4B). The
reduced penetrance is consistent with this variant being present in the
population at lower frequency. A second variant was detected in this
family in PVRL3; however, it did not segregate with the phenotype.
Although it is not clear whether the rareCRYGA variant is responsible
for the disease in this family, it remains the best candidate mutation
observed to date in family CRCH139 and may represent a deleterious
variant of lower penetrance.
Families CRCH89 and CRCH136 displayed an autosomal recessive
inheritancepatternof cataract.Affectedmembersof theconsanguineous
family, CRCH89, were homozygous for a novel variant [p.(Phe364Ser)]
in GCNT2 predicted to be pathogenic (Figure 5). The four affected
siblings all had bilateral pediatric cataracts with surgery in the first
few weeks to 1 year of age (Table 2). A single heterozygous variant in
GCNT2 resulting in a premature stop codon [p.(Asn388Argfs20)] was
detected in family CRCH136 and was inherited from the unaffected
mother. No other variant was identified in GCNT2 in this family.
A segregating stop mutation [p.(Gly211)] in MIP was detected in
family CSA131 (Figure 5). The mother (CSA131.04) had cortical and
nuclear sclerotic cataracts with multiple cortical dots, while two other
affected members (CSA131.01 and CSA131.02) had anterior cortical
spokes and white dot cataracts (Table 2). This family also carried a
mutation in FYCO1; however, the latter variant was predicted to be
benign and did not segregate with the disease.
Mutations meeting the criteria for potential pathogenicity were not
identified in the remaining 19 families (57%) or the other 43 genes
screened on this gene panel.
In this study, we used targeted massively parallel sequencing to
identify genetic variants associatedwith inherited pediatric cataract.We
identified likely causative variants in42%ofpreviouslyunsolved familial
cases.Wedetected11novelmutations contributing topediatric cataract,
confirmed three previously reported mutations, and identified rare
codingvariants thatmaybe important in thedisease.Wehavepreviously
identified mutations in genes included in this panel in other families in
our repository (Sharma et al. 2008; Burdon et al. 2004a,b, 2007; Reches
et al. 2007; Dave et al. 2013; Craig et al. 2003; McLeod et al. 2002;
Javadiyan et al. 2016). When considered together with our earlier pub-
lished work, these 51 genes account for 62% of familial pediatric cata-
ract, a proportion comparable to that reported in a similar study of
patients from the UK (Gillespie et al. 2014) and another Australian
cohort (Ma et al. 2016).
The phenotypes observed in these families, where detailed informa-
tion is available, are similar to previous reports of mutations in these
genes. For example, we describe predominantly nuclear phenotypes
related to mutations in the gap junction genes GJA3 and GJA8 (Shiels
et al. 2010). Similarly, nuclear or total cataracts are observed in CRYAA
mutation carriers (Khan et al. 2007; Devi et al. 2008) while mutations in
CRYBB2 give rise to cortical and lamellar cataracts (Devi et al. 2008;
Faletra et al. 2013).
Figure 3 Pedigree and Sanger sequencing analysis of families with variants in gap junction genes (GJA3 and GJA8). The chromatograms below
each pedigree show the sequence detected via Sanger sequencing for each variant in families, and the gene names and mutation at cDNA and
protein level have been mentioned on each pedigree. The penetrance of mutations in family CRCH20 (GJA8, c.73T . C) is incomplete. The
arrowheads indicate the proband sequenced on the gene panel by AmpliSeq. Solid circles indicate affected females and solid squares show the
affected males.
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Homozygousor compoundheterozygousmutations inGCNT2have
been reported in families with autosomal recessive cataract (Borck et al.
2012). Affected individuals in family CRCH136 carry a single copy of a
4 bp frameshift deletion [p.(Asn388Argfs20)] in GCNT2. Although
segregation in this family is consistent with autosomal recessive inher-
itance (Figure 5), a second mutation in GCNT2 or in any other gene in
the panel could not be identified in the proband. The affected individ-
uals had bilateral dense central opacities, similar to those reported by
Borck et al. (2012) in other families with a homozygousmutation in this
gene, and are also similar to those seen in family CRCH89 in which a
Figure 4 Pedigree and Sanger sequencing analysis of families with variants in (A) a crystallins (CRYAA); (B) b and g crystallins (CRYBB2, CRYGA,
and CRYGS). The penetrance of mutations in family CRCH139 (CRYGA, c.239G . A) is incomplete. The variants in PVRL3 in CRCH139 do not
segregate with the phenotype. The segregating variant in BFAP2 in CRVEEH85 was predicted to be nonpathogenic by both SIFT and Polyphen-2.
The arrowheads indicate the proband sequenced on the gene panel by AmpliSeq. Solid circles indicate affected females and solid squares show
the affected males. Diagonal lines indicate the person is deceased. The chromatograms below each pedigree show the Sanger sequencing result
of each detected variant in family members. The gene names and mutation at cDNA and protein level have been mentioned on each pedigree.
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homozygous GCNT2 mutation was identified. It is possible that the
second mutation in family CRCH136 was not detectable by the meth-
ods employed in this study, whichmay include partial gene deletions or
mutations affecting noncoding regions. The possibility that this muta-
tion does not contribute to the disease in this family cannot be excluded
but is considered less likely.
This work highlights the not-infrequent occurrence of mutations
with incomplete penetrance in pediatric cataract. We observed re-
duced penetrance with mutations in GJA8 (CRCH20) and CRYGA
(CRCH139). This suggests the involvement of modifier genes alter-
ing the penetrance of these mutations and the severity of the cata-
ract; however, such genes have not yet been identified (Maeda et al.
2001). There have been previous reports of reduced penetrance with
mutations in GJA3 in families with total cortical (Devi et al. 2005)
and nuclear lamellar pulverulent (Burdon et al. 2004b) cataracts.
Furthermore, there has been one report of reduced penetrance of a
mutation in CRYBB2 associated with congenital zonular cataract
(Santhiya et al. 2010).
The possible involvement of rare variants present in public databases
in pediatric cataract pathogenesis is suggested by this study. Family
CRCH139 has a segregating rare variant inCRYGA (rs139353014) with
incomplete penetrance. Other factors, including high level of conser-
vation at this residue and Polyphen-2 prediction of a functional effect,
provide support for contribution of this mutation to cataract in this
family. The incomplete penetrance is consistent with the presence of
this variant at very low levels in public databases and our local controls.
If this variant does not always lead to disease, it would be expected to
accumulate in such databases. As public databases increase in size, and
are generated from unscreened individuals, we expect that, increas-
ingly, disease-causing variants will be found at low frequency in these
resources. This scenario of disease-causing variants being represented
in public databases of genetic variation due to the large numbers of
individuals sequenced is well exemplified by the p.Gln368mutation in
the MYOC gene, which leads to primary open-angle glaucoma with
high penetrance and is present in the 1000 Genomes database with a
frequency of 0.06% as rs74315329. Such rare variation should not be
automatically discounted when evaluating variants as pathogenic in
disease cohorts. SIFT and ACMG predictions of benign for the
Arg80His variant of CRCH139 make it difficult to comment on the
pathogenicity of this variant without any functional studies. Other
possibilities, such as the causative variant being intronic, in a novel
not-yet-reported gene (or not included in this panel), or a large struc-
tural variant should not be ignored.
In the current study, 2% of amplicons were covered ,20 fold,
potentially limiting the ability to detect heterozygous mutations in
these amplicons. By chance, the majority of the 16 genes containing
these low coverage amplicons are involved in syndromic forms of
pediatric cataract. In this study, only five probands had syndromic
Figure 5 Pedigree and Sanger sequencing analysis of families with variants in GCNT2 andMIP. The arrowheads indicate the proband sequenced
on the gene panel by AmpliSeq. Solid circles indicate affected females and solid squares show the affected males. The double line in CRCH89
shows consanguinity. The chromatograms below each pedigree show the segregation analysis of the variants in families. The gene names and
mutation at cDNA and protein level have been mentioned on each pedigree.
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pediatric cataracts and no mutations were identified in these individ-
uals. It may be that mutations were missed due to low coverage, or
that these individuals have mutations in genes not targeted by this
panel. Furthermore, it is important to comment that this study is not
able to detect large insertions or deletions or any structural variants
such as copy number variation (CNV) within screened genes. Such
variants have been reported in the literature to be associated with the
disease (Siggs et al. 2017; Burdon et al. 2007; Van Esch et al. 2007).
One of the main advantages of the AmpliSeq method on the Ion
Torrent PGM is that it only requires 10–40 ng of DNA as starting
material. Many of the DNA samples used in this study were.10 years
old, and the limited quantity ofDNA availablewas somewhat degraded.
The successful sequencing of these samples and identification of likely
causative mutations suggests that quality of DNA is not necessarily
a crucial factor in obtaining reliable sequencing results using this
methodology.
Pediatric cataract is a clinically and genetically heterogeneous con-
dition, which makes accurate molecular diagnosis difficult. Genetic
linkage analysis and candidate gene screening are the conventional
methods fordetectingdisease-causinggenes for familialdiseases,but this
approach is limited by the size of the families. In small families, as in this
current cohort, gene identificationhas beendifficult due to lack ofpower
for linkageand theexcessivecostof screening largenumbersof candidate
genes using traditional Sanger sequencing. MPS platforms are able to
target numerous genes in parallel and are cost-effective tools for gene
identification in heterogeneous conditions such as pediatric cataract. In
this study,we aimed to determine the genetic contribution of the known
pediatric cataract genes to inherited pediatric cataract in an Australian
cohort. In our experience, both ophthalmologists and their patients are
highly motivated to know the genetic basis of their disease. Developing
genetic diagnostic panels increases the chance of obtaining a molecular
diagnosis, which allows patients and their families to be better educated
about the mode of inheritance, and facilitates more accurate genetic
counseling about the risk of recurrence for future pregnancies, enabling
discussion regarding possible reproductive options. For example, the
parents in family CSA159 enrolled in this research study during a
pregnancy with a desire to understand the likelihood of the child being
affected with the severe disease observed in their son.
Although some degree of genotype/phenotype correlation is begin-
ning to emerge for some pediatric cataract genes, the clinical evaluation
of a patient is often insufficient to establish which genes are most likely
involved in order to initiate specific genetic testing. This is particularly
the case in historic samples where surgery was performed prior to
enrolment in this study. These genotype-phenotype correlations are
worthy of further study, as genetic counseling in the future should take
account of the likely severity of affected status, the likelihood of systemic
manifestation, and the chance of incomplete penetrance. Gene panel
testing, as has been shown in previous studies (Gillespie et al. 2014) and
here in an Australian cohort, is therefore an efficient way to rapidly
determine the genetic cause of heterogeneous diseases such as pediatric
cataract. In our cohort of cases, the chosen panel of 51 genes would
cover 62% of causative mutations.
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